...
首页> 外文期刊>Chemical engineering journal >Black phosphorus nanosheets-based nanocarriers for enhancing chemotherapy drug sensitiveness via depleting mutant p53 and resistant cancer multimodal therapy
【24h】

Black phosphorus nanosheets-based nanocarriers for enhancing chemotherapy drug sensitiveness via depleting mutant p53 and resistant cancer multimodal therapy

机译:基于黑色磷纳米片的纳米载体通过消耗突变体P53和抗性癌症多式联疗法提高化疗药物敏感性

获取原文
获取原文并翻译 | 示例
           

摘要

Chemotherapy resistance hinders the successful clinical cancer therapy, because of the low sensitivity of drugs to resistant cancer cells. In resistant cancer cells, the mutant p53 possesses anti-apoptosis capability to tolerate chemotherapeutic drugs such as doxorubicin (DOX). Phenethyl isothiocyanate (PEITC) derived from cruciferous vegetables can deplete intracellular mutant p53. In this work, the black phosphorus nanosheets-based (BPN-sbased) drug delivery system integrated with PEITC can effectively decrease mutant p53 level in resistant cancer cells and realize multiple drug resistance (MDR) reversal. The intrinsic properties of BPNs could achieve synergistic photothermal/photodynamic/chemo-therapy of resistant cancer. Magnetic resonance imaging (MRI) is used to investigate the biodistribution of nanoparticles which confirmed the efficient accumulations of nano-particles at tumor sites. In vitro and in vivo anticancer experiments demonstrate the drug resistance tumor is effectively inhibited with minimal side effects by BPNs-based drug delivery system.
机译:化疗抗性阻碍了成功的临床癌症疗法,因为药物对抗性癌细胞的敏感性低。在耐药性癌细胞中,突变体P53具有抗凋亡能力,可耐受化学治疗药物如多柔比星(DOX)。衍生自十字芥菜的苯乙基异硫氰酸酯(PEITC)可以耗尽细胞内突变体P53。在这项工作中,与PeITC集成的基于黑磷酸纳米蛋白酶(BPN-SBASED)药物递送系统可以有效地降低抗性癌细胞中的突变P53水平,并实现多种耐药性(MDR)逆转。 BPN的内在特性可以达到抗性癌症的协同光热/光动力/化学治疗。磁共振成像(MRI)用于研究纳米颗粒的生物分布,该生物分布证实肿瘤位点的有效纳米颗粒的纳米颗粒累积。体外和体内抗癌实验证明了BPNS的药物递送系统的副作用最小的副作用。

著录项

  • 来源
    《Chemical engineering journal》 |2019年第2019期|共13页
  • 作者单位

    Cent S Univ Coll Chem &

    Chem Engn Changsha 410083 Hunan Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Normal Univ Sch Chem &

    Mat Sci Jiangsu Key Lab Biofunct Mat Jiangsu Collaborat Innovat Ctr Biomed Funct Mat Nanjing 210023 Jiangsu Peoples R China;

    Cent S Univ Coll Chem &

    Chem Engn Changsha 410083 Hunan Peoples R China;

    Cent S Univ Coll Chem &

    Chem Engn Changsha 410083 Hunan Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学工业;
  • 关键词

    Chemotherapy resistance; Mutant p53; PEITC; BPNs-based; Synergistic photothermal/photodynamic/chemo-therapy;

    机译:化疗抗性;突变体P53;PEITC;基于BPNS;协同光热/光动力/化学疗法;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号